A Window-of-opportunity Study of Pelareorep in Early Breast Cancer (AWARE-1)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04102618 |
|
Recruitment Status :
Terminated
(Enrollment into AWARE cohorts1-4 have concluded and the primary objective and core goals for the study were met.)
First Posted : September 25, 2019
Last Update Posted : August 15, 2022
|
Sponsor:
Oncolytics Biotech
Collaborator:
SOLTI Breast Cancer Research Group
Information provided by (Responsible Party):
Oncolytics Biotech
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | April 20, 2022 |
| Actual Study Completion Date : | April 20, 2022 |